(Q43715249)

26 November 2017

title

Reversal of reserpine-induced vacuous chewing movements in rats by melatonin: involvement of peripheral benzodiazepine receptors (English)

1 reference

26 November 2017

0 references

V Raghavendra

1

1 reference

26 November 2017

P S Naidu

series ordinal

2

1 reference

26 November 2017

S K Kulkarni

series ordinal

3

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

26 November 2017

1 reference

26 November 2017

volume

904

1 reference

26 November 2017

issue

1

1 reference

26 November 2017

page(s)

149-152

1 reference

Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia?

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902455-6

Melatonin: Effects on brain and behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902455-6

Oral dyskinesia in rats following brain lesions and neuroleptic drug administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902455-6

Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902455-6

The nullification by diazepam of haloperidol-induced increases in the level of striatal dopamine but not in the activity of glutamic acid decarboxylase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902455-6

Co-administration of progabide inhibits haloperidol-induced oral dyskinesias in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902455-6

Dose-dependent differences in the development of reserpine-induced oral dyskinesia in rats: support for a model of tardive dyskinesia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902455-6

Reversal of morphine tolerance and dependence by melatonin: possible role of central and peripheral benzodiazepine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902455-6

Anti-depressant action of melatonin in chronic forced swimming-induced behavioral despair in mice, role of peripheral benzodiazepine receptor modulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902455-6

Attenuation of reserpine-induced catalepsy by melatonin and the role of the opioid system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902455-6

Tardive dyskinesia associated with depression in a bipolar patient: possible role of melatonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902455-6

Sustained improvement in tardive dyskinesia with diazepam: Indirect evidence for corticolimbic involvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902455-6

Mechanisms underlying the antidopaminergic effect of clonazepam and melatonin in striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902455-6

Clonazepam treatment of tardive dyskinesia: a practical GABAmimetic strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902455-6

Preclinical evaluation of the reinforcing and discriminative stimulus effects of agomelatine (S-20098), a melatonin agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902455-6

10.1016/S0006-8993(01)02455-6

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference